Answers are grounded in this paper and cite their sources.
Analysis shows yeast surface expression of VP1 improves immune response against foot-and-mouth disease virus, suggesting a potential oral vaccine approach.
Our study indicates that yeast surface expressed VP1 elicits a superior immune response against FMDV than intracellularly expressed VP1 for immune response against FMDV, which offers a potential breakthrough in the effort to provide a simple and highly effective oral vaccine.
No takes yet. Share an insight, caveat, or question.
Chun et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: